Drug
Mp0274
Mp0274: highest development phase Phase 1, developed by Molecular Partners. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Molecular Partners
Trials
| Drug | Phase | Indication |
|---|---|---|
| MP0274 NCT03084926 | Phase 1 | Neoplasms |
Latest
No recent events.
Follow Mp0274 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.